Angiosarcoma Awareness Inc

Why angiosarcoma research matters

Angiosarcoma is a rare type of cancer that affects the inner lining of blood vessels or lymph vessels. There is ongoing research on angiosarcoma, aimed at improving the understanding of its causes, developing new diagnostic methods, and finding more effective treatments. Some include:

Genetics

Researchers are mapping the genetic mutations behind angiosarcoma, but progress is slow due to limited funding and small patient populations for clinical studies.

Diagnosis

New imaging techniques and biopsy methods are improving early detection—critical because angiosarcoma is often misdiagnosed in its earliest stages.

Treatment

Clinical trials are testing immunotherapies and targeted drugs designed to attack angiosarcoma cells while sparing healthy tissue—treatments that didn't exist five years ago.

Prognosis

Researchers are identifying which patients respond best to specific treatments—data that helps oncologists choose more effective therapy combinations.

How we accelerate progress

Angiosarcoma Awareness has awarded grants to further research and patient advocacy.

LTD dollars granted

Support research

We fund laboratories conducting angiosarcoma research—from genetic studies to clinical trials testing new treatments.

Advocacy Partner

We are a proud advocacy partner of the Angiosarcoma Project, a direct-to-patient genomics research study being conducted at the Broad Institute of MIT and Harvard.

Patient Support

We help newly diagnosed patients find oncologists experienced in treating angiosarcoma and connect families with others facing this rare cancer.

Fundraising

Every dollar funds research, patient navigation, and medical education.

Angiosarcoma Awareness combines patient advocacy with research funding. The results of their efforts have led to numerous patients receiving care at sarcoma centers of excellence, and have translated into rapid progress in understanding this disease on a molecular level with respect to disease research. Angiosarcoma Awareness provides a resounding voice for patients with angiosarcoma. We truly value our relationship with them and feel fortunate to have such a wonderful ally in our battle against this terrible disease.

DR. WILLIAM D. TAP, MD CHIEF

Sarcoma Medical Oncology Service Memorial Sloan-Kettering Cancer Center

Angiosarcoma Awareness